Students of the Creativity, Innovation and New Value course at Colorado State University discuss the popular teaching case study “Boehringer Ingelheim: Leading Innovation” (available at Harvard Business Review (HBR) and the Ivey Business School) with intrapreneur Stephan Klaschka.
Intrapreneurship Case Study at the Foreign Trade University (FTU),
As a cooperation between Colorado State University (CSU) and the Foreign Trade University (FTU) in Hanoi, Vietnam, FTU students are tasked to develop an opportunity in a team and conduct a feasibility analysis on the opportunity that they present to the class on June 4, 2018.
In this teaching case study, the case writers Professor J. Robert Mitchell, Ph.D., and Ramasastry Chandrasekhar, of Ivey Business School, follow the footsteps of Stephan Klaschka’s intrapreneurial approach to innovation within a global pharmaceutical company (FORTUNE Global 500, Top 20 Pharma).
This intrapreneurship teaching case study is used by staff and students of Intrapreneurship and Innovation in business schools around the world. and features my career as an Intrapreneur at a major pharmaceutical company.
The panel will cover innovations and trends in the health tech space and will feature Alex Fair, CEO of Medstartr, a leading medtech fund, accelerator and crowdfunding platform, Loren Busby, angel investor with Mid Atlantic Bio Angels, and Mette Dyhrberg, Founder of MyMee, a successful big data symptom management startup. It is an event you won’t want to miss!Wednesday, March 29, 2017 from 6:00 PM to 9:00 PM (EDT)
GACCNY’s Health Tech Insight Panel
We are excited to partner on a new collaboration with the German American Chamber of Commerce (GACC): an expert panel event focused on innovations in health-tech.
The panel will cover innovations and trends in the health tech space and will feature Alex Fair, CEO of Medstartr, a leading medtech fund, accelerator and crowdfunding platform, Loren Busby, angel investor with Mid Atlantic Bio Angels, and Mette Dyhrberg, Founder of MyMee, a successful big data symptom management startup. It is an event you won’t want to miss!
Wednesday, March 29, 2017 from 6:00 PM to 9:00 PM (EDT)
Spark Labs (Bryant Park)
25 West 39th St.
14th Floor
New York, NY 10018
Agenda
6:00pm Registration, Networking & Snacks
6:30pm Panel Discussion: Life Science
7:45pm More Networking & Snacks
About VentureOut
VentureOut, the event organizer, is focused on enabling the world’s most promising technology organizations to launch into new markets, raise capital, and scale. Based on the philosophy that talent is evenly distributed but opportunity is not, VentureOut’s mission is to bridge that gap between the entrepreneurial talent around the world and the vast opportunities available to them in New York City & San Francisco. Through short-form strategy development and capital raising programs, VentureOut immerses the world’s most talented entrepreneurs into the US technology ecosystem, fast tracking their growth by establishing relationships with top tech influencers, investors, and new prospective clients. To date, VentureOut has supported the growth of over 500 companies (700+ entrepreneurs) from 20 different countries. VentureOut was founded by Brian Frumberg in 2012. (www.ventureoutny.com)
Expert advice on open innovation from executives with experience at Bayer, Lilly and Boehringer Ingelheim published in the December/January 2017 issue of the Healthcare Sales & Marketing Magazine (HS&M) e-magazine:
The Art of Innovation: How to Become a “Partner of Choice” is an insightful interview with seasoned innovation professionals discussing what it takes to build a Partner-of Choice-relationship with Open Innovation in the pharmaceutical industry.
The Art of Innovation: How to Become a “Partner of Choice” is an insightful interview with seasoned innovation professionals discussing what it takes to build a Partner-of Choice-relationship with Open Innovation in the pharmaceutical industry.
This video addresses the question: How can the pharmaceutical industry reskill representatives to be knowledgeable consultants to physicians?
Today, sales expertise is not enough. The pharmaceutical representative needs to be a broker of information. Physicians now have very limited time – and dictate when they can meet with representatives, from whom they need comprehensive information that they can pass along to their increasingly educated patients.
In this video, Jo Ann Saitta, Chief Digital Officer of the CDM Group, Stephan Klaschka, Innovation and Healthcare Consultant, and moderator, Richie Etwaru, Chief Digital Officer at Cegedim, examine this shift and the challenges pharmaceutical companies may face in properly retraining their people. These challenges include: adopting a culture of learning agility; integrating silos of information; having the ability to serve up dynamic content; and training representatives to utilize technologies that will maximize their brief but demanding visits with physicians.
Use this linkto watch all 10 videos in the series on YouTube directly – enjoy!
10 Inevitable Changes in Pharma 2015 – Communication moving to Collaboration
Angela Miccoli
Wendy Mayer
10 Inevitable Changes in Pharma 2015 – Content moving to Context
James Corbett
Craig DeLarge
10 Inevitable Changes in Pharma 2015 – Care moving to Cure
Michael DePalma
John Nosta
10 Inevitable Changes in Pharma 2015 – Compliance moving to Culture
Bill Buzzeo
Gus Papandrikos
10 Inevitable Changes in Pharma 2015 – Supply Chains moving to Supply Constellations
Ray Wang
Aron Dutta
10 Inevitable Changes in Pharma 2015 – Customization moving to Configuration
Tracy Maines
Krishna Cheriath
10 Inevitable Changes in Pharma 2015 – Customer moving to Consumer
Paul Kandle
Mark Stevens
10 Inevitable Changes in Pharma 2015 – Calls moving to Consults
Jo Ann Saitta
Stephan Klaschka
10 Inevitable Changes in Pharma 2015 – Cloud moving to Crowd
Les Jordan
Krishnan Sridharan
10 Inevitable Changes in Pharma 2015- Charity moving to Cause
Read this insightful “Taking the entrepreneurial approach” interview conducted by Eyeforpharma on the impact of hierarchy and how executive mindset inhibits adapting to the rapidly changing commercial landscape. It outlines how “intrapreneurs” and internal “angel investors” can get large, mature organizations moving again!